| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 23 Feb 25 | SUPN Supernus Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 2,500 | 0.00 | 14,091 |
| 23 Feb 25 | SUPN Supernus Pharmaceuticals | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 2,500 | 0.00 | 5,000 |
| 22 Feb 25 | SUPN Supernus Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 3,000 | 0.00 | 11,591 |
| 22 Feb 25 | SUPN Supernus Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 500 | 0.00 | 8,591 |
| 22 Feb 25 | SUPN Supernus Pharmaceuticals | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 3,000 | 0.00 | 9,000 |
| 22 Feb 25 | SUPN Supernus Pharmaceuticals | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 500 | 0.00 | 500 |
| 19 Feb 25 | SUPN Supernus Pharmaceuticals | RSU Common Stock | Grant | Acquire A | No | No | 0 | 4,500 | 0.00 | 4,500 |
| 19 Feb 25 | SUPN Supernus Pharmaceuticals | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 33.52 | 40,000 | 1.34 mm | 40,000 |
| 23 Feb 24 | SUPN Supernus Pharmaceuticals | Common Stock | Payment of exercise | Dispose F | No | No | 29.06 | 1,314 | 38.18 k | 7,190 |
| 23 Feb 24 | SUPN Supernus Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 2,500 | 0.00 | 8,504 |
